Cetera Advisor Networks LLC Compugen LTD Transaction History

Cetera Advisor Networks LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 13, 2024	SELL	$0.53 - $2.0 $337 - $1,272	-636 Reduced 4.1%	14,859 $29,000
Q3 2023 Nov 14, 2023	BUY	$0.88 - $1.31 $13,635 - $20,298	15,495 New	15,495 $14,000
Q4 2021 Feb 14, 2022	SELL	$4.09 - $7.16 $79,346 - $138,904	-19,400 Closed	0 $0
Q3 2021 Nov 16, 2021	BUY	$5.8 - $8.02 $17,400 - $24,060	3,000 Added 18.29%	19,400 $116,000
Q2 2021 Aug 13, 2021	BUY	$6.87 - $9.16 $35,724 - $47,632	5,200 Added 46.43%	16,400 $136,000
Q1 2021 May 17, 2021	BUY	$7.67 - $13.77 $85,904 - $154,224	11,200 New	11,200 $96,000

13.1M

79.2K

12.7K

Ticker CGEN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 86,624,600
Market Cap $129M
Description
Compugen Ltd., a clinical-stage therapeutic discovery and development company, researches, develops, and commercializes therapeutic and product candidates in Israel, the United States, and Europe. The company's immuno-oncology pipeline consists of COM701, an anti-PVRIG antibody that is in Phase I clinical study used for the treatment of solid tu...

Get notified when there are updates to the investment portfolio of Cetera Advisor Networks LLC, based on Form 13F filings with the SEC.

Stay updated on Cetera Advisor Networks LLC with notifications on news.